SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-035081
Filing Date
2019-09-20
Accepted
2019-09-20 09:00:40
Documents
15
Period of Report
2019-09-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20190920.htm   iXBRL 8-K 45575
2 EX-99.1 fgen-ex991_6.htm EX-99.1 52247
3 GRAPHIC g34gh13buyut000001.jpg GRAPHIC 32885
4 GRAPHIC g34gh13buyut000002.jpg GRAPHIC 17196
  Complete submission text file 0001564590-19-035081.txt   305584

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA fgen-20190920.xsd EX-101.SCH 6201
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20190920_lab.xml EX-101.LAB 19070
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20190920_pre.xml EX-101.PRE 11723
14 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20190920_htm.xml XML 3404
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 191102732
SIC: 2834 Pharmaceutical Preparations